Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey.
Solveig K SmedslandKathrine F VandraasSynne K BøhnAlv A DahlCecilie E KiserudMette BrekkeRagnhild S FalkKristin V ReinertsenPublished in: Breast cancer research and treatment (2022)
Treatment with aromatase inhibitor seems to affect sexual health even beyond discontinuation. Several common late effects were associated with sexual inactivity and reduced sexual functioning. To identify BCSs at risk of sexual dysfunction, special attention should be paid to patients treated with aromatase inhibitor or suffering from these late effects.